| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.09 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.1 |